KGI Faculty Edit Two New Journals on Rare Disorders and Orphan Drugs
Dr. Ian Phillips, director of KGI’s Center for Rare Disease Therapies and co-sponsor of the institute’s Rare Disease Day Symposium is editing two new journals on rare diseases. He is the editor-in-chief of Expert Opinion on Orphan Drugs and a co-editor with Dr. Tim Coté, professor of practice, of The Journal of Rare Disorders.
Expert Opinion on Orphan Drugs is a monthly publication providing a forum for reviews, editorials and evaluations on current developments in orphan drugs. The first edition of the journal was published in January.
The Journal of Rare Disorders is a peer-reviewed, clinically oriented, quarterly publication covering research, regulatory issues, review articles, case reports and editorials on the latest advances in diagnosis and treatment of rare diseases. It is currently accepting manuscript submissions.
“There has not been a single journal in the United States that brings together published papers on rare disease research and orphan drugs,” Phillips said. “Most research publications are scattered among specialty medical journals or business journals. But the topics and interest in orphan disease are far reaching. So it’s very rewarding to bring together for the first time two new journals on rare diseases and edit them from the Center for Rare Disease Therapies at KGI.”
The Journal of Rare Disorders is published by Scientific Communications Group in New Jersey. It will be published quarterly with an option to publish more frequently. It will cover all issues about rare disease. Expert Opinion on Orphan Drugs is published monthly by the UK-based Informa Healthcare and covers more of the business side of rare disease drugs. The new journals have received a lot of interest from scientists, doctors and patients.